Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in APELLIS PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 178,888 shares of APLS (APELLIS PHARMACEUTICALS INC), worth $4.5M as of 2025-Q4. The position was increased (++6.8% shares). APLS represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$4.5M
Current Shares
178,888
Total Value Change
-$3.5M
Total Shares Change
-29,296
Other major holders of APLS: BANQUE PICTET & CIE SA, BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS, Avoro Capital Advisors LLC
Increased |
| 178,888 |
+6.8% |
| $4.5M |
| 0.0% |
| $25.24 |
29 |
| 2025-Q3 | Decreased | 167,464 | -44.5% | $3.8M | 0.0% | $22.65 | 0 |
| 2025-Q2 | Increased | 301,939 | +35.6% | $5.2M | 0.0% | $17.43 | 35 |
| 2025-Q1 | Increased | 222,634 | +4.6% | $4.9M | 0.0% | $24.27 | 28 |
| 2024-Q4 | Increased | 212,887 | +11.4% | $6.8M | 0.0% | $31.90 | 30 |
| 2024-Q3 | Decreased | 191,065 | -8.2% | $5.5M | 0.0% | $29.47 | 0 |
| 2024-Q2 | Increased | 208,184 | +49.4% | $8M | 0.0% | $38.36 | 38 |